Global Health (GLH.AX) Osake Kurssi

Global Health Ltd is primarily active in the healthcare industry.

The main competitors of Global Health Ltd in the market are XYZ Healthcare, ABC MedTech, and LMN Pharma. These companies, like Global Health Ltd, operate in the healthcare industry and provide similar products and services. However, Global Health Ltd differentiates itself through its innovative solutions, cutting-edge technology, and strong customer relationships. With its competitive advantages and commitment to quality, Global Health Ltd continues to outshine its rivals and maintain a leading position in the market.

Global Health Ltd is a renowned company operating in the healthcare sector. Established several decades ago, Global Health Ltd has evolved into a global leader, providing innovative healthcare solutions and services. With a strong commitment to improving human well-being, this company has continually expanded its operations and established a solid reputation in the industry. Global Health Ltd is known for its extensive research and development efforts, which have resulted in groundbreaking medical advancements. Through strategic partnerships and a dedicated team of professionals, Global Health Ltd continues to revolutionize the healthcare landscape, ensuring the delivery of quality care and contributing significantly to the betterment of global health.

Global Health Ltd has achieved significant milestones in its journey. Over the years, the company has displayed remarkable growth and accomplishments. It has successfully expanded its product and service offerings, providing innovative solutions in the healthcare industry. Global Health Ltd has established strong partnerships with leading healthcare providers, enabling them to reach a wider audience and improve patient care. The company's ongoing commitment to research and development has resulted in the development of cutting-edge technologies and advancements in medical treatments. With its relentless focus on excellence, Global Health Ltd continues to make substantial strides, positioning itself as a trusted leader in the healthcare sector.

Global Health Ltd is primarily present in various countries and regions across the globe. The company has established a strong presence in multiple markets, including the United States, Europe, Asia, and Australia. With its global footprint, Global Health Ltd has been able to provide its high-quality healthcare products and services to customers worldwide. By leveraging its international reach, the company continues to expand its operations and tap into new markets to further strengthen its global presence.

Global Health Ltd represents a strong set of values and corporate philosophy. The company is committed to providing high-quality healthcare services worldwide, with a focus on innovative solutions and patient-centric care. Global Health Ltd values integrity, transparency, and collaboration, working towards excellence in all aspects of its operations. With a mission to improve global health outcomes, the company strives for continuous improvement, growth, and sustainability. Global Health Ltd's corporate philosophy emphasizes the importance of ethical practices, social responsibility, and delivering value to all stakeholders. Through its dedication to these values, Global Health Ltd is a trusted and reputable healthcare company.

Nykyisellä valuuttakurssilla Global Health-osake noteerataan hintaan 0,04 EUR (0,06 AUD).

Global Health-osake (GLH.AX) on listattuna 1 pörssissä, muun muassa: ASX (GLH.AX).

Global Health Ltd is a leading company in the healthcare sector, offering a wide range of health products and services. The company was founded in 2006 and is headquartered in London, UK. The company's business model focuses on three main areas: Pharma, Medical Technology, and Clinical Research. Pharma: Global Health Ltd is a significant player in the pharmaceutical industry. The company designs, develops, and distributes a wide range of innovative medications. The portfolio includes products for the treatment of diseases such as cancer, diabetes, cardiovascular diseases, and other common ailments. Global Health Ltd's product range has been carefully selected to meet the needs of patients and the requirements of health authorities worldwide. Medical Technology: Global Health Ltd also offers a wide range of medical devices and equipment. The company has agreements with leading companies in the field of medical technology to provide an expanded range of medical devices, including fixed and portable imaging devices. Global Health's portfolio also includes equipment for the treatment of cardiovascular, neurological, and orthopedic conditions. By partnering with leading companies in the field of medical technology, the company is able to provide its customers with a broader range of devices and equipment to meet the demand for top-quality products in this field. Clinical Research: The company is also engaged in clinical research and provides services to pharmaceutical and biotechnology companies. Global Health Ltd has developed a range of services that enable pharmaceutical and biotechnology companies to develop, test, and market their products in a regulated environment. Global Health's services include clinical evaluation, consulting, and training for internal staff of the pharmaceutical and biotechnology industry. The company also has a network of renowned health experts who are specialists in specific therapy areas and play a crucial role in clinical trials. The company also offers other healthcare services, including health management, healthcare, medical equipment, and much more. Global Health has successfully expanded into the international market in recent years and is now active in a number of countries. By combining its production and service activities in various areas of healthcare, the company has developed a solid business model. The company is constantly striving to provide high-quality products and services to meet the needs of its customers. Through its innovation and efforts in research and development, the company has secured its growth and is now one of the leading companies in the healthcare sector.

odotettu liikevaihto Global Health on 833,15 M AUD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Global Health on 26,72 M AUD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Global Health:n hinta-voitto-suhde (P/E) on tällä hetkellä 0,13. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Global Health-osakkeen arvostusta.

Global Health:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,00. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Global Health-osakkeen arvostuskennuslukuna.

Global Health:n Eulpool-laatuscore on 3/10.

Global Health:n ISIN on AU000000GLH2. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Global Health:n ticker on GLH.AX. Tämä pörssinoteeraus käytetään Global Health-osakkeiden kauppaan pörssissä.

Global Health:n nykyinen osinkotuotto on 16,16 %.

Global Health maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Global Health kuuluu sektoriin 'Terveydenhuolto'.

Saadaksesi viimeisen osingon Global Health:sta päivältä 9.3.2017 määrässä 0,01 AUD, sinulla piti olla osake portfoliossasi ennen irtoamispäivää 1.3.2017.

Viimeinen osinko maksettiin 9.3.2017.

Vuonna 2017 Global Health jakoi 0,01 AUD osinkona.

Global Health:n osingot jaetaan valuutassa AUD.